Cargando…

Follow-up of COVID-19 recovered patients with mild disease

COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Kashif, Alina, Chaudhry, Manahil, Fayyaz, Tehreem, Abdullah, Mohammad, Malik, Ayesha, Anwer, Javairia Manal Akmal, Inam, Syed Hashim Ali, Fatima, Tehreem, Iqbal, Noreena, Shoaib, Khadija
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239036/
https://www.ncbi.nlm.nih.gov/pubmed/34183705
http://dx.doi.org/10.1038/s41598-021-92717-8
_version_ 1783715001174851584
author Kashif, Alina
Chaudhry, Manahil
Fayyaz, Tehreem
Abdullah, Mohammad
Malik, Ayesha
Anwer, Javairia Manal Akmal
Inam, Syed Hashim Ali
Fatima, Tehreem
Iqbal, Noreena
Shoaib, Khadija
author_facet Kashif, Alina
Chaudhry, Manahil
Fayyaz, Tehreem
Abdullah, Mohammad
Malik, Ayesha
Anwer, Javairia Manal Akmal
Inam, Syed Hashim Ali
Fatima, Tehreem
Iqbal, Noreena
Shoaib, Khadija
author_sort Kashif, Alina
collection PubMed
description COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of the 11 studied symptoms were notably more prevalent amongst the female sample population. Our results validate the presence of prolonged symptoms months after recovery from mild COVID-19 disease, particularly in association with the female gender. Hence, proving the post-COVID syndrome is a recognizable diagnosis in the bigger context of the post-viral fatigue syndrome.
format Online
Article
Text
id pubmed-8239036
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-82390362021-07-06 Follow-up of COVID-19 recovered patients with mild disease Kashif, Alina Chaudhry, Manahil Fayyaz, Tehreem Abdullah, Mohammad Malik, Ayesha Anwer, Javairia Manal Akmal Inam, Syed Hashim Ali Fatima, Tehreem Iqbal, Noreena Shoaib, Khadija Sci Rep Article COVID-19 may manifest as mild, moderate or severe disease with each grade of severity having its own features and post-viral implications. With the rising burden of the pandemic, it is vital to identify not only active disease but any post-recovery complications as well. This study was conducted with the aim of identifying the presence of post-viral symptomatology in patients recovered from mild COVID-19 disease. Presence or absence of 11 post-viral symptoms was recorded and we found that 8 of the 11 studied symptoms were notably more prevalent amongst the female sample population. Our results validate the presence of prolonged symptoms months after recovery from mild COVID-19 disease, particularly in association with the female gender. Hence, proving the post-COVID syndrome is a recognizable diagnosis in the bigger context of the post-viral fatigue syndrome. Nature Publishing Group UK 2021-06-28 /pmc/articles/PMC8239036/ /pubmed/34183705 http://dx.doi.org/10.1038/s41598-021-92717-8 Text en © Crown 2021 https://creativecommons.org/licenses/by/4.0/ Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Kashif, Alina
Chaudhry, Manahil
Fayyaz, Tehreem
Abdullah, Mohammad
Malik, Ayesha
Anwer, Javairia Manal Akmal
Inam, Syed Hashim Ali
Fatima, Tehreem
Iqbal, Noreena
Shoaib, Khadija
Follow-up of COVID-19 recovered patients with mild disease
title Follow-up of COVID-19 recovered patients with mild disease
title_full Follow-up of COVID-19 recovered patients with mild disease
title_fullStr Follow-up of COVID-19 recovered patients with mild disease
title_full_unstemmed Follow-up of COVID-19 recovered patients with mild disease
title_short Follow-up of COVID-19 recovered patients with mild disease
title_sort follow-up of covid-19 recovered patients with mild disease
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239036/
https://www.ncbi.nlm.nih.gov/pubmed/34183705
http://dx.doi.org/10.1038/s41598-021-92717-8
work_keys_str_mv AT kashifalina followupofcovid19recoveredpatientswithmilddisease
AT chaudhrymanahil followupofcovid19recoveredpatientswithmilddisease
AT fayyaztehreem followupofcovid19recoveredpatientswithmilddisease
AT abdullahmohammad followupofcovid19recoveredpatientswithmilddisease
AT malikayesha followupofcovid19recoveredpatientswithmilddisease
AT anwerjavairiamanalakmal followupofcovid19recoveredpatientswithmilddisease
AT inamsyedhashimali followupofcovid19recoveredpatientswithmilddisease
AT fatimatehreem followupofcovid19recoveredpatientswithmilddisease
AT iqbalnoreena followupofcovid19recoveredpatientswithmilddisease
AT shoaibkhadija followupofcovid19recoveredpatientswithmilddisease